Skip to main content
. 2021 Oct 19;61(10):1531–1536. doi: 10.2169/internalmedicine.8305-21

Table 1.

Results of Laboratory Blood Examination on Admission.

TP 7.8 g/dL AFP 941.8 ng/mL
Albumin 4.8 g/dL AFP-L3 1.80 %
BUN 11 mg/dL PIVKA-II 1,170 mAU/mL
Cre 0.49 mg/dL CEA 0.5 ng/mL
AST 18 U/L CA19-9 13.2 U/mL
ALT 12 U/L HBsAg (-)
γ-GTP 16 U/L HBsAb (-)
ALP 216 U/L HBcAb (-)
T-bil 0.6 mg/dL HCVAb (-)
LDH 161 U/L IgG 1,179 mg/dL
Na 140 mmol/L IgM 294 mg/dL
K 3.8 mmol/L ANA <40
Cl 106 mmol/L AMA <20
ChE 263 U/L
HbA1c 5.3 % Fe 35.8 ng/mL
WBC 9,320 /μL Cu 107 μg/dL
RBC 498×104 /μL TC 204 mg/dL
Hb 13.8 g/dL TG 55 mg/dL
Plt 26.4×104 /μL
PT-INR 1.06 %
APTT 42.2 s

TP: total protein, BUN: blood urea nitrogen, Cre: creatinine, AST: aspartate aminotransferase, ALT: alanine aminotransferase, γ-GTP: γ-glutamyl transferase, ALP: alkaline phosphatase, T-bil: total bilirubin, LDH: lactate dehydrogenase, ChE: cholinesterase, WBC: white blood cell, RBC: red blood cell, Hb: hemoglobin, Plt: platelet, PT-INR: prothrombin time-international normalized ratio, APTT: activated partial thromboplastin time, AFP: alpha-fetoprotein, PIVKA-II: protein induced by vitamin K absence or antagonist II, HBsAg: hepatitis B surface antigen, HBsAb: hepatitis B surface antibody, HBcAb: hepatitis B core antibody, HCVAb: hepatitis C virus antibody, ANA: antinuclear antibody, AMA: anti-mitochondrial antibody, TC: total cholesterol, TG: triglyceride